# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The Dow Jones closed higher by over 100 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When ...
HC Wainwright & Co. analyst Vernon Bernardino maintains AIkido Pharma (NASDAQ:AIKI) with a Buy and lowers the price targ...
-Reuters
- SEC Form4 Filing
- SEC Form4 Filing
AIkido Pharma Inc. (NASDAQ:AIKI) ("AIkido" or the "Company") today confirms that on August 9, 2022, the Company...
Proposal for All-Cash Transaction Represents a 31% Premium to AIKI's Most Recent Closing Price Urges the Board to Immedi...
Significant Investor in AIkido Pharma Issues Open Letter to Board of Directors Continued Destruction of Value and Poor Corpora...